Evaluating the Impact of Enhanced Recovery After Surgery (ERAS )Protocol on Analgesic Consumption in Orthognathic Surgery
Phase 3
Recruiting
- Conditions
- Orthognathic surgery.Congenital malformation of face and neck, unspecifiedQ18.9
- Registration Number
- IRCT20120430009593N16
- Lead Sponsor
- Shahid Beheshti University of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 50
Inclusion Criteria
Patients Candidates for Orthognathic Surgery under General Anesthesia
Primary deformity
ASA ClassI,II
Filling out the Patient's Informed Consent Form
Exclusion Criteria
History of Opioid Usage
History of Post -Operative Nausea and Vomiting
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Remifentanil Consumption During Operation. Timepoint: Every 1 hour During Operation. Method of measurement: Remifentan Infusion Dosage Based on Microgram.
- Secondary Outcome Measures
Name Time Method Propofol Consumption During Operation. Timepoint: Every 1 hour during operation. Method of measurement: Propofol Consumption Based on Milligram per Hour.;Post-Op Visual Analogue Scale. Timepoint: Recovery and at 2, 4, 6, 12 and 24 hours. Method of measurement: Visual Analogue scale based on 0 to 10.;Antihypertensive Drug Consumption during Operation. Timepoint: Every 1 hr. Method of measurement: Antihypertensive Consumption Based on Miligram.;Incidence of Post -Operative Nausea. Timepoint: 2, 4, 6, 12 , 24 hours. Method of measurement: Patient expression.;Incidence of Post -Operative Vomiting. Timepoint: At 2, 4, 6, 12 and 24 hours. Method of measurement: Patient Expression.